Phenomenological and Psychopathological Factors Associated to Hallucinations in Parkinson's Disease (HALLUPARK)
Status
Conditions
Treatments
Details and patient eligibility
About
This study aims to describe hallucinations prevalence in a sample of patients affected by Parkinson's disease and consulting in an outpatient facility.
An unique one hour interview will be offered to volunteers patients. Patients participating to the study will be asked to answer a semi-structured questionnaire searching for hallucinations of all modalities, minor psychotic symptoms and delusions. Psychometric scales will be assessed to search for depressive symptoms, cognitive impairment and specific personality characteristics.
The study hypothesis is that hallucinations prevalence in Parkinson's disease is underestimated and is higher than usually described in the scientific literature when all hallucinations modalities and minor hallucinatory phenomenons are searched for.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Age ≥ 18 years-old
- Absence of opposition from the patient himself/herself or his/her legal representant for his/her participation to the study
- Patient without superior age limit with a diagnosis of Parkinson's disease made according to the UKPDSBB criteria (UK Parkinson's Disease Society Brain Bank clinical diagnostic criteria)
- Outpatient consulting in neurology at the Charpennes'hospital
Exclusion criteria
- Opposition to the study
- Deafness or blindness which could compromise the interview
Trial design
32 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal